Drug Delivery Market

Global Drug Delivery Market by Administration (Nasal, Oral, Injectable, Pulmonary, Topical, Ocular, Implantable, and Others), Types (Conventional and Advanced), Applications (Cancer, Respiratory Diseases, Diabetes, Infectious Diseases, Cardiovascular Diseases, and Others), Distribution Channels (Retail Pharmacies, Hospital Pharmacies, and Others), End-users (Hospitals, Home Healthcare, Ambulatory Surgical Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-4150
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 52
  • No. Of Pages: 220
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global drug delivery market size was valued at around USD 258 billion in 2020 and is anticipated to reach around USD 394 billion by 2028, expanding at a CAGR of about 7.40% during the forecast period, 2021 – 2028. The growth of the market is attributed to the rising prevalence of chronic diseases and increasing technological advancements.

Drug Delivery Market Key Takeaways

Drug delivery refers to methods, approaches, or processes of administrating pharmaceutical drugs safely into body to attain its desired therapeutic effects. The practice of drug delivery changes continuously, as biomedical engineers research about new modes of drug delivery to pass through any physiological barriers. For example, research regarding nanocrystals and their use as a novel drug delivery method contribute to technological advancements in the drug delivery market. Pharmaceutical companies, biomedical engineers, and Contract Development and Manufacturing Organizations (CDMOs) develop drug delivery techniques to improve patient compliance. Technological advancements and rising chronic diseases are driving the global drug delivery market.

The COVID-19 pandemic outbreak led to the need to improve care for patients, adopt new drugs to improve immunity, and stock drugs for future use. Rising vaccination during the pandemic spurred the growth of the market.

Market Trends, Drivers, Restraints, and Opportunities

  • Growth in the biologics market boosts the global drug delivery market.
  • Rising prevalence of chronic diseases and growing geriatric population are expected to drive the market during the forecast period.
  • Growing awareness of self-administered drug delivery devices among consumers spur the growth of the market.
  • Rising research & development expenditure and increasing technological advancements are projected to expand the market during the forecast period.
  • Growing preference of patients regarding advanced drug delivery devices such as auto-injectors, insulin jets, dry powder inhalers, wearables, and others boost the market.
  • Strict regulations and guidelines regarding the approval of new drug delivery devices and product recalls are anticipated to hinder the growth of the market.
  • Risk of needlestick injuries hamper the growth of the market.
  • Self-administration and home care for growing geriatric population offer lucrative opportunities for key players to develop and launch products, which is expected to boost the market.

Scope of the Report

The report on the global drug delivery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Drug Delivery Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Administration (Nasal, Oral, Injectable, Pulmonary, Topical, Ocular, Implantable, and Others), Types (Conventional and Advanced), Applications (Cancer, Respiratory Diseases, Diabetes, Infectious Diseases, Cardiovascular Diseases, and Others), Distribution Channels (Retail Pharmacies, Hospital Pharmacies, and Others), End-users (Hospitals, Home Healthcare, Ambulatory Surgical Centers, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Johnson & Johnson; Pfizer, Inc.; Antares Pharma, Inc.; Biocorp Production; Novartis International AG; Elcam Medical; Becton, Dickinson, and Company; West Pharmaceutical Services, Inc.; Ypsomed Holding; Medtronic, Plc.; Gilead Sciences, Inc.; The 3M Company; Teva Pharmaceutical Industries, Ltd.; Sanofi S.A.; and Others

Market Segment Insights

Injectable drug administration registers a significant growth

Based on administration, the market is segmented into nasal, oral, injectable, topical, ocular, pulmonary, implantable, and others. The injectable segment is expected to dominate the market during the forecast period, owing to its ability to deliver drugs to the target site. Increasing vaccination drives globally is expected to spur the market in the coming years. The oral segment registers high growth, due to its cost-effectiveness, convenience of administration, and ease in manufacturing drugs in oral dosage form.

Advanced segment emerges as a fast-growing segment

On the basis of types, the market is bifurcated into conventional and advanced. The conventional segment accounts for a key share of the market; however, the advanced segment is anticipated to expand at a rapid pace during the forecast period. Rising demand for user-friendly, target-specific, user-compatible, less-invasive, and drug delivery devices with less side-effects is anticipated to boost the market.

Infectious diseases segment accounted for a large share of the market

Based on applications, the market is divided into cancer, respiratory diseases, diabetes, infectious diseases, cardiovascular diseases, and others. The infectious diseases segment is estimated to dominate the market during the forecast period, due to increasing prevalence of infectious diseases globally. Increasing research & develop expenditure for new drugs, due to COVID-19 pandemic situation, and rising Food and Drug Administration (FDA) approvals for such drugs propel the market.

Drug Delivery Market By Applications

Hospital pharmacies drive the market

Based on distribution channels, the market is segregated into retail pharmacies, hospital pharmacies, and others. The hospital pharmacies market is expected to dominate the market during the forecast period, due to rising drug delivery from hospital pharmacies. With prevailing diseases, increasing hospital admissions, and advancements in hospital facilities, the hospital pharmacies segment boosts the market. The retail pharmacies segment is expanding at a significant rate, due to easy availability of drug delivery devices in retail pharmacies, and growing preferences of consumers of self-injectable and self-monitoring devices. 

Home healthcare is expected to expand at a significant rate

On the basis of end-users, the market is divided into hospitals, home healthcare, ambulatory surgical centers, and others. The home healthcare segment is anticipated to drive the market during the forecast period, owing to growing awareness of hospital-acquired diseases, increasing geriatric population, and rising disposable income.

North America is expected to dominate the market

Based on regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market is North America is projected to expand at a significant CAGR, due to rising number of chronic diseases such as diabetes, cancer, respiratory allergies, and others, growing geriatric population, and presence of large number of key players in the region who focus on developing and launching products. Large number of pharmaceutical companies, growing research & development expenditure, and technological advancements are expected to drive the market in the region.

Segments

The global drug delivery market has been segmented on the basis of

Administration
  • Nasal
  • Oral
  • Injectable
  • Pulmonary
  • Topical
  • Ocular
  • Implantable
  • Others
Types
  • Conventional
  • Advanced
Applications
  • Cancer
  • Respiratory Diseases
  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others
Distribution Channels
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others
End-users
  • Hospitals
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Johnson & Johnson
  • Pfizer, Inc.
  • Antares Pharma, Inc.
  • Biocorp Production
  • Novartis International AG
  • Elcam Medical
  • Becton, Dickinson, and Company
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding
  • Medtronic, Plc.
  • Gilead Sciences, Inc.
  • The 3M Company
  • Teva Pharmaceutical Industries, Ltd.
  • Sanofi S.A.
  • Others

Competitive Landscape

Key players such as Johnson & Johnson; Pfizer, Inc.; Antares Pharma, Inc.; Biocorp Production; Novartis International AG; Elcam Medical; Becton, Dickinson, and Company; West Pharmaceutical Services, Inc.; Ypsomed Holding; Medtronic, Plc.; Gilead Sciences, Inc.; The 3M Company; Teva Pharmaceutical Industries, Ltd.; Sanofi S.A.; and others use strategies such as mergers, acquisitions, collaborations, partnerships, and product launches to dominate the global drug delivery market. In November 2020, Medtronic launched InPen, which provides real-time glucose readings and insulin dosage information. In May 2021, Becton, Dickinson, and Company announced an investment of USD 200 millions in a new facility in Spain to support the growth of its pre-filled drug delivery business.

Drug Delivery Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug Delivery Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug Delivery Market - Supply Chain
  4.5. Global Drug Delivery Market Forecast
     4.5.1. Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug Delivery Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Drug Delivery Market Absolute $ Opportunity
5. Global Drug Delivery Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Drug Delivery Market Size and Volume Forecast by Types
     5.3.1. Conventional
     5.3.2. Advanced
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Drug Delivery Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Drug Delivery Market Size and Volume Forecast by Applications
     6.3.1. Cancer
     6.3.2. Respiratory Diseases
     6.3.3. Diabetes
     6.3.4. Infectious Diseases
     6.3.5. Cardiovascular Diseases
     6.3.6. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Drug Delivery Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. Drug Delivery Market Size and Volume Forecast by End Users
     7.3.1. Hospitals
     7.3.2. Home Healthcare
     7.3.3. Ambulatory Surgical Centers
     7.3.4. Others
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Drug Delivery Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. Drug Delivery Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global Drug Delivery Demand Share Forecast, 2019-2026
9. North America Drug Delivery Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America Drug Delivery Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America Drug Delivery Market Size and Volume Forecast by Types
     9.4.1. Conventional
     9.4.2. Advanced
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America Drug Delivery Market Size and Volume Forecast by Applications
     9.7.1. Cancer
     9.7.2. Respiratory Diseases
     9.7.3. Diabetes
     9.7.4. Infectious Diseases
     9.7.5. Cardiovascular Diseases
     9.7.6. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America Drug Delivery Market Size and Volume Forecast by End Users
     9.10.1. Hospitals
     9.10.2. Home Healthcare
     9.10.3. Ambulatory Surgical Centers
     9.10.4. Others
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America Drug Delivery Demand Share Forecast, 2019-2026
10. Latin America Drug Delivery Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America Drug Delivery Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America Drug Delivery Market Size and Volume Forecast by Types
     10.4.1. Conventional
     10.4.2. Advanced
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America Drug Delivery Market Size and Volume Forecast by Applications
     10.7.1. Cancer
     10.7.2. Respiratory Diseases
     10.7.3. Diabetes
     10.7.4. Infectious Diseases
     10.7.5. Cardiovascular Diseases
     10.7.6. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America Drug Delivery Market Size and Volume Forecast by End Users
     10.10.1. Hospitals
     10.10.2. Home Healthcare
     10.10.3. Ambulatory Surgical Centers
     10.10.4. Others
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America Drug Delivery Demand Share Forecast, 2019-2026
11. Europe Drug Delivery Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe Drug Delivery Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe Drug Delivery Market Size and Volume Forecast by Types
     11.4.1. Conventional
     11.4.2. Advanced
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe Drug Delivery Market Size and Volume Forecast by Applications
     11.7.1. Cancer
     11.7.2. Respiratory Diseases
     11.7.3. Diabetes
     11.7.4. Infectious Diseases
     11.7.5. Cardiovascular Diseases
     11.7.6. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe Drug Delivery Market Size and Volume Forecast by End Users
     11.10.1. Hospitals
     11.10.2. Home Healthcare
     11.10.3. Ambulatory Surgical Centers
     11.10.4. Others
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe Drug Delivery Demand Share Forecast, 2019-2026
12. Asia Pacific Drug Delivery Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific Drug Delivery Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific Drug Delivery Market Size and Volume Forecast by Types
     12.4.1. Conventional
     12.4.2. Advanced
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific Drug Delivery Market Size and Volume Forecast by Applications
     12.7.1. Cancer
     12.7.2. Respiratory Diseases
     12.7.3. Diabetes
     12.7.4. Infectious Diseases
     12.7.5. Cardiovascular Diseases
     12.7.6. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific Drug Delivery Market Size and Volume Forecast by End Users
     12.10.1. Hospitals
     12.10.2. Home Healthcare
     12.10.3. Ambulatory Surgical Centers
     12.10.4. Others
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific Drug Delivery Demand Share Forecast, 2019-2026
13. Middle East & Africa Drug Delivery Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa Drug Delivery Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa Drug Delivery Market Size and Volume Forecast by Types
     13.4.1. Conventional
     13.4.2. Advanced
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa Drug Delivery Market Size and Volume Forecast by Applications
     13.7.1. Cancer
     13.7.2. Respiratory Diseases
     13.7.3. Diabetes
     13.7.4. Infectious Diseases
     13.7.5. Cardiovascular Diseases
     13.7.6. Others
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa Drug Delivery Market Size and Volume Forecast by End Users
     13.10.1. Hospitals
     13.10.2. Home Healthcare
     13.10.3. Ambulatory Surgical Centers
     13.10.4. Others
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa Drug Delivery Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global Drug Delivery Market: Market Share Analysis
  14.2. Drug Delivery Distributors and Customers
  14.3. Drug Delivery Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. Johnson & Johnson
     14.4.2. Pfizer, Inc.
     14.4.3. Antares Pharma, Inc.
     14.4.4. Biocorp Production
     14.4.5. Novartis International AG
     14.4.6. Elcam Medical
     14.4.7. Becton, Dickinson, and Company
     14.4.8. West Pharmaceutical Services, Inc.
     14.4.9. Ypsomed Holding
     14.4.10. Medtronic, Plc.
     14.4.11. Gilead Sciences, Inc.
     14.4.12. The 3M Company
     14.4.13. Teva Pharmaceutical Industries, Ltd.
     14.4.14. Sanofi S.A.
     14.4.15. Others
The global drug delivery market has been segmented on the basis of

Administration
  • Nasal
  • Oral
  • Injectable
  • Pulmonary
  • Topical
  • Ocular
  • Implantable
  • Others
Types
  • Conventional
  • Advanced
Applications
  • Cancer
  • Respiratory Diseases
  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others
Distribution Channels
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others
End-users
  • Hospitals
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Johnson & Johnson
  • Pfizer, Inc.
  • Antares Pharma, Inc.
  • Biocorp Production
  • Novartis International AG
  • Elcam Medical
  • Becton, Dickinson, and Company
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding
  • Medtronic, Plc.
  • Gilead Sciences, Inc.
  • The 3M Company
  • Teva Pharmaceutical Industries, Ltd.
  • Sanofi S.A.
  • Others

Key players such as Johnson & Johnson; Pfizer, Inc.; Antares Pharma, Inc.; Biocorp Production; Novartis International AG; Elcam Medical; Becton, Dickinson, and Company; West Pharmaceutical Services, Inc.; Ypsomed Holding; Medtronic, Plc.; Gilead Sciences, Inc.; The 3M Company; Teva Pharmaceutical Industries, Ltd.; Sanofi S.A.; and others use strategies such as mergers, acquisitions, collaborations, partnerships, and product launches to dominate the global drug delivery market. In November 2020, Medtronic launched InPen, which provides real-time glucose readings and insulin dosage information. In May 2021, Becton, Dickinson, and Company announced an investment of USD 200 millions in a new facility in Spain to support the growth of its pre-filled drug delivery business.

Drug Delivery Market By Key Players

Buy Report